AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

96,100

Employees96,100

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

96,100

Employees96,100

AZN Key Statistics

Market cap

289.51B

Market cap289.51B

Price-Earnings ratio

26.62

Price-Earnings ratio26.62

Dividend yield

1.68%

Dividend yield1.68%

Average volume

3.50M

Average volume3.50M

High today

$188.99

High today$188.99

Low today

$184.96

Low today$184.96

Open price

$186.85

Open price$186.85

Volume

1.73M

Volume1.73M

52 Week high

$212.71

52 Week high$212.71

52 Week low

$153.41

52 Week low$153.41

Stock Snapshot

AstraZeneca(AZN) stock is priced at $186.76, giving the company a market capitalization of 289.51B. It carries a P/E multiple of 26.62 and pays a dividend yield of 1.68%.

On 2026-11-10, AstraZeneca(AZN) stock traded between a low of $184.96 and a high of $188.99. Shares are currently priced at $186.76, which is +1.0% above the low and -1.2% below the high.

AstraZeneca(AZN) shares are trading with a volume of 1.73M, against a daily average of 3.5M.

During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.

AZN News

Seeking Alpha 7h

AstraZeneca acquires preclinical biotech Omniose

AstraZeneca acquires preclinical biotech Omniose Nov 10, 2026, 11:21 AM ET AstraZeneca PLC (AZN) Stock By : Jonathan Block, SA News Editor AstraZeneca has acqui...

The Wall Street Journal 1d

Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

TipRanks 4d

AstraZeneca Advances New Ovarian Cancer Combination Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s TREVI-OC-02 study is testing torvutatug samrotecan...

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

Sell

9.1%

More AZN News

TipRanks 4d

AstraZeneca Advances China Cancer Trial as Durvalumab Takes Center Stage

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s Phase 3 MATTERHORN-CN study is testing treatment fo...

The Wall Street Journal 6d

AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals

AstraZeneca CEO Pascal Soriot Michael Nagle / Bloomberg News AstraZeneca AZN 1.92 %increase; up pointing triangle recently made a roughly $10 billion offer to...

TipRanks 6d

AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World In...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.